For the treatment of respiratory diseases, anticholinergics and β- mimetics new combination drug

The present invention describes respiratory diseases including airway inflammation or obstruction such as chronic obstructive pulmonary disease (COPD) and for the treatment of asthma, the combination drug of the anticholinergic and β- mimetics. Topical application (inhalation) Preparation of the concomitant drug in the dosage, and the inhaler further comprises the application of, for example, Novolizer (R).